Brain-gut interaction in the pathophysiology of IBS

Journal of Japanese Society of Gastroenterology

Volumn 111, Issue 7, 2014, Pages 1334-1344

  Okumura, Toshikatsu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AFFERENT PATHWAYS; BRAIN; HUMANS; INTESTINES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IRRITABLE BOWEL SYNDROME; MAGNETIC RESONANCE IMAGING; NEUROPEPTIDES; PAIN PERCEPTION;

EID: 84905818568     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Drossman DA : The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130; 1377-1390 : 2006
2. Longstreth GF, Thompson WG, Chey WD, et al : Functional bowel disorders. Gastroenterology 130; 1480-1491 : 2006
3. Mayer EA, Gebhart GF : Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107; 271-293 : 1994
4. Ogawa S, Lee TM, Kay AR, et al : Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 87; 9868-9872 : 1990
5. Drossman DA, Ringel Y, Vogt BA, et al : Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 124; 754-761 : 2003
6. Tillisch K, Mayer EA, Labus JS : Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 140; 91-100 : 2011
7. Zhang ZH, Dougherty PM, Oppenheimer SM : Monkey insular cortex neurons respond to baroreceptive and somatosensory convergent inputs. Neuroscience 94; 351-360 : 1999
8. Berthier M, Starkstein S, Leiguarda R : Asymbolia for pain : a sensory-limbic disconnection syndrome. Ann Neurol 24; 41-49 : 1988
9. Hutchison WD, Davis KD, Lozano AM, et al : Pain-related neurons in the human cingulate cortex. Nat Neurosci 2; 403-405 : 1999
10. Iwata K, Kamo H, Ogawa A, et al : Anterior cingulate cortical neuronal activity during perception of noxious thermal stimuli in monkeys. J Neurophysiol 94; 1980-1991 : 2005
11. Greenspan JD, Lee RR, Lenz FA : Pain sensitivity alterations as a function of lesion location in the parasylvian cortex. Pain 81; 273-282 : 1999
12. Berman SM, Naliboff BD, Suyenobu B, et al : Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci 28; 349-359 : 2008
13. Shapiro RE, Miselis RR : The central neural connections of the area postrema of the rat. J Comp Neurol 234; 344-364 : 1985
14. Bouhassira D, Moisset X, Jouet P, et al : Changes in the modulation of spinal pain processing are related to severity in irritable bowel syndrome. Neurogastroenterol Motil 25; 623-e468 : 2013
15. Rosenberger C, Thürling M, Forsting M, et al : Contributions of the cerebellum to disturbed central processing of visceral stimuli in irritable bowel syndrome. Cerebellum 12; 194-198 : 2013
16. Blankstein U, Chen J, Diamant NE, et al : Altered brain structure in irritable bowel syndrome : potential contributions of pre-existing and diseasedriven factors. Gastroenterology 138; 1783-1789 : 2010
17. Davis KD, Pope G, Chen J, et al : Cortical thinning in IBS : implications for homeostatic, attention, and pain processing. Neurology 70; 153-154 : 2008
18. Piché M, Chen JI, Roy M, et al : Thicker posterior insula is associated with disease duration in women with irritable bowel syndrome (IBS) whereas thicker orbitofrontal cortex predicts reduced pain inhibition in both IBS patients and controls. J Pain 14; 1217-1226 : 2013
19. Seminowicz DA, Labus JS, Bueller JA, et al : Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology 139 ; 48-57.e2 : 2010
20. Chen JY, Blankstein U, Diamant NE, et al : White matter abnormalities in irritable bowel syndrome and relation to individual factors. Brain Res 1392; 121-131 : 2011
21. Hong JY, Kilpatrick LA, Labus J, et al : Patients with chronic visceral pain show sex-related alterations in intrinsic oscillations of the resting brain. J Neurosci 33; 11994-12002 : 2013
22. Labus JS, Gupta A, Coveleskie K, et al : Sex differences in emotion-related cognitive processes in irritable bowel syndrome and healthy control subjects. Pain 154; 2088-2099 : 2013
23. Lackner JM, Lou Coad M, Mertz HR, et al : Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety. Behav Res Ther 44; 621-638 : 2006
24. Morgan V, Pickens D, Gautam S, et al : Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 54; 601-607 : 2005
25. Lowén MB, Mayer EA, Sjöberg M, et al : Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther 37; 1184-1197 : 2013
26. Lee HF, Hsieh JC, Lu CL, et al : Enhanced affect/cognition-related brain responses during visceral placebo analgesia in irritable bowel syndrome patients. Pain 153; 1301-1310 : 2012
27. Lieberman MD, Jarcho JM, Berman S, et al : The neural correlates of placebo effects : a disruption account. Neuroimage 22; 447-455 : 2004
28. Petrovic P, Kalso E, Petersson KM, et al : A prefrontal non-opioid mechanism in placebo analgesia. Pain 150; 59-65 : 2010
29. Aizawa E, Sato Y, Kochiyama T, et al : Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on FMRI and dynamic causal modeling. Gastroenterology 143; 1188-1198 : 2012
30. Labus JS, Hubbard CS, Bueller J, et al : Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome. Gastroenterology 145 ; 1253-1261.e1-e3 : 2013
31. Tillisch K, Labus J, Nam B, et al : Neurokinin-1- receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome : a pilot study. Aliment Pharmacol Ther 35; 360-367 : 2012
32. Taché Y, Stephens RL Jr, Ishikawa T : Central nervous system action of TRH to influence gastrointestinal function and ulceration. Ann N Y Acad Sci 553; 269-285 : 1989
33. Taché Y, Bonaz B : Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 117; 33-40 : 2007
34. Fukudo S : Stress and visceral pain : focusing on irritable bowel syndrome. Pain 154 (suppl 1); S63- S70 : 2013
35. Stengel A, Taché Y : Neuroendocrine control of the gut during stress : corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol 71; 219-239 : 2009
36. Nozu T, Tsuchiya Y, Kumei S, et al : Peripheral corticotropin-releasing factor (CRF) induces stimulation of gastric contractions in freely moving conscious rats : role of CRF receptor types 1 and 2. Neurogastroenterol Motil 25; 190-197 : 2013
37. Nozu T, Kumei S, Takakusaki K, et al : Water-avoidance stress enhances gastric contractions in freely moving conscious rats : role of peripheral CRF receptors. J Gastroenterol 49; 799-805 : 2014
38. Uehara A, Okumura T, Sekiya C, et al : Interleukin-1 inhibits the secretion of gastric acid in rats : possible involvement of prostaglandin. Biochem Biophys Res Commun 162; 1578-1584 : 1989
39. Okumura T, Uehara A, Okamura K, et al : Inhibition of gastric pepsin secretion by peripherally or centrally injected interleukin-1 in rats. Biochem Biophys Res Commun 167; 956-961 : 1990
40. Uehara A, Okumura T, Kitamori S, et al : Interleukin-1 : a cytokine that has potent antisecretory and anti-ulcer actions via the central nervous system. Biochem Biophys Res Commun 173; 585-590 : 1990
41. Okumura T, Uehara A, Tsuji K, et al : Central nervous system action of basic fibroblast growth factor : inhibition of gastric acid and pepsin secretion. Biochem Biophys Res Commun 175; 527- 531 : 1991
42. Okumura T, Uehara A, Kitamori S, et al : Prevention by interleukin-1 of intracisternally injected thyrotropin-releasing hormone (TRH)-induced gastric mucosal lesions in rats. Neurosci Lett 125; 31-33 : 1991
43. Okumura T, Uehara A, Kitamori S, et al : Central basic fibroblast growth factor inhibits gastric ulcer formation in rats. Biochem Biophys Res Commun 177; 809-813 : 1991
44. Okumura T, Uehara A, Kitamori S, et al : Basic fibroblast growth factor (bFGF) acts centrally in the brain to inhibit gastric emptying in rats. Neurosci Lett 137; 53-55 : 1992
45. Okumura T, Uehara A, Watanabe Y, et al : Sitespecific formation of thyrotropin-releasing hormone-induced gastric ulcers through the vagal system. Scand J Gastroenterol 29; 226-231 : 1994
46. Okumura T, Pappas TN, Taylor IL : Stimulation of gastric secretion and enhanced gastric mucosal damage following central administration of pancreatic polypeptide (PP) in rats. Dig Dis Sci 39; 2398-2406 : 1994
47. Okumura T, Pappas TN, Taylor IL : Intracisternal injection of pancreatic polypeptide stimulates gastric emptying in rats. Neurosci Lett 178; 167- 170 : 1994
48. Okumura T, Fukagawa K, Tso P, et al : Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorus-ligated concious rats. Gastroenterology 107; 1861-1864 : 1994
49. Okumura T, Pappas TN, Taylor IL : Pancreatic polypeptide microinjection into the dorsal motor nucleus inhibits pancreatic secretion in rats. Gastroenterology 108; 1517-1525 : 1995
50. Okumura T, Taylor IL, Pappas TN : Microinjection of TRH analogue into the dorsal vagal complex simulates pancreatic secretion in rats. Am J Physiol 269; G328-G334 : 1995
51. Okumura T, Grant AP, Taylor IL, et al : Gastric mucosal damage induced by 2-deoxy-D-glucose involves medullary TRH in the rat. Regul Pept 55; 311-319 : 1995
52. Okumura T, Taylor IL, Ohning G, et al : Intracisternal injection of TRH antibody blocks gastric emptying stimulated by 2-deoxy-D-glucose in rats. Brain Res 674; 137-141 : 1995
53. Okumura T, Taylor IL, Fukagawa K, et al : Apolipoprotein A-IV acts centrally in the brain to reduce the severity of gastric ulceration in the rat. Brain Res 673; 153-156 : 1995
54. Okumura T, Fukagawa K, Tso P, et al : Mechanism of action of intracisternal apolipoprotein AIV in inhibiting gastric acid secretion in rats. Gastroenterology 109; 1583-1588 : 1995
55. Okumura T, Fukagawa K, Tso P, et al : Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. Am J Physiol 270; G49-G53 : 1996
56. Okumura T, Yamada H, Motomura W, et al : Cocaine-amphetamine-regulated transcript (CART) acts in the central nervous system to inhibit gastric acid secretion via brain corticotropin-releasing factor system. Endocrinology 141; 2854-2860 : 2000
57. Krowicki ZK : Role of selected peptides in the vagal regulation of gastric motor and endocrine pancreatic function. J Physiol Pharmacol 47; 399- 409 : 1996
58. Taché Y, Raybould H, Wei JY : Central and peripheral actions of calcitonin gene-related peptide on gastric secretory and motor function. Adv Exp Med Biol 298; 183-198 : 1991
59. Taché Y, Garrick T, Raybould H : Central nervous system action of peptides to influence gastrointestinal motor function. Gastroenterology 98; 517-528 : 1990
60. Kaneko H, Mitsuma T, Nagai H, et al : Central action of adrenomedullin to prevent ethanolinduced gastric injury through vagal pathways in rats. Am J Physiol 274; R1783-R1788 : 1998
61. Holmes GM, Browning KN, Babic T, et al : Vagal afferent fibres determine the oxytocin-induced modulation of gastric tone. J Physiol 591; 3081- 3100 : 2013
62. Xia ZF, Fritze DM, Li JY, et al : Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats. Am J Physiol Gastrointest Liver Physiol 303; G570-G577 : 2012
63. Atsuchi K, Asakawa A, Ushikai M, et al : Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport 21; 1008-1011 : 2010
64. Stengel A, Goebel M, Wang L, et al : Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats : differential role of corticotropin-releasing factor2 receptor. Endocrinology 150; 4911-4919 : 2009
65. Geoghegan JG, Lawson DC, Cheng CA, et al : Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog. Gastroenterology 105; 1069-1077 : 1993
66. Chen CH, Rogers RC : Central inhibitory action of peptide YY on gastric motility in rats. Am J Physiol 269; R787-R792 : 1995
67. Asakawa A, Ataka K, Fujino K, et al : Ghrelin family of peptides and gut motility. J Gastroenterol Hepatol 26 (suppl 3); 73-74 : 2011
68. Date Y, Nakazato M, Murakami N, et al : Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 280; 904-907 : 2001
69. Li Y, Owyang C : Pancreatic secretion evoked by cholecystokinin and non-cholecystokinindependent duodenal stimuli via vagal afferent fibres in the rat. J Physiol 494; 773-782 : 1996
70. Sakurai T, Amemiya A, Ishii M, et al : Orexins and orexin receptors : a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92; 573-585 : 1998
71. de Lecea L, Kilduff TS, Peyron C, et al : The hypocretins : hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95; 322-327 : 1998
72. Takahashi N, Okumura T, Yamada H, et al : Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats. Biochem Biophys Res Commun 254; 623-627 : 1999
73. Okumura T, Takeuchi S, Motomura W, et al : Requirement of intact disulfide bonds in orexin-Ainduced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. Biochem Biophys Res Commun 280; 976-981 : 2001
74. Nozu T, Tuchiya Y, Kumei S, et al : Endogenous orexin-A in the brain mediates 2-deoxy-D-glucose- induced stimulation of gastric motility in freely moving conscious rats. J Gastroenterol 47; 404-411 : 2012
75. Nozu T, Kumei S, Takakusaki K, et al : Central orexin-A increases colonic motility in conscious rats. Neurosci Lett 498; 143-146 : 2011
76. Okumura T, Namiki M : Vagal motor neurons innervating the stomach are site-specifically organized in the dorsal motor nucleus of the vagus nerve in rats. J Auton Nerv Syst 29; 157-162 : 1990
77. Yamada H, Okumura T, Motomura W, et al : Inhibition of food intake by central injection of antiorexin antibody in fasted rats. Biochem Biophys Res Commun 267; 527-531 : 2000
78. Hwang LL, Chen CT, Dun NJ : Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro. J Physiol 537; 511-520 : 2001
79. Krowicki ZK, Burmeister MA, Berthoud HR, et al : Orexins in rat dorsal motor nucleus of the vagus potently stimulate gastric motor function. Am J Physiol Gastrointest Liver Physiol 283; G465-G472 : 2002
80. Yamada H, Takahashi N, Tanno S, et al : A selective orexin-1 receptor antagonist, SB334867, blocks 2-DG-induced gastric acid secretion in rats. Neurosci Lett 376; 137-142 : 2005
81. Miyasaka K, Masuda M, Kanai S, et al : Central Orexin-A stimulates pancreatic exocrine secretion via the vagus. Pancreas 25; 400-404 : 2002
82. Okumura T, Takakusaki K : Role of orexin in central regulation of gastrointestinal functions. J Gastroenterol 43; 652-660 : 2008
83. Yamada H, Tanno S, Takakusaki K, et al : Intracisternal injection of orexin-A prevents ethanol-induced gastric mucosal damage in rats. J Gastroenterol 42; 336-341 : 2007
84. Tsujino N, Sakurai T : Orexin/hypocretin : a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 61; 162-176 : 2009
85. Takakusaki K, Takahashi K, Saitoh K, et al : Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol 568; 1003-1020 : 2005
86. Lutter M, Krishnan V, Russo SJ, et al : Orexin signaling mediates the antidepressant-like effect of calorie restriction. J Neurosci 28; 3071-3075 : 2008
87. Ito N, Yabe T, Gamo Y, et al : I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation. Neuroscience 157; 720-732 : 2008
88. Brundin L, Björkqvist M, Petersén A, et al : Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol 9; 573-579 : 2007
89. Okumura T, Nozu T : Role of brain orexin in the pathophysiology of functional gastrointestinal disorders. J Gastroenterol Hepatol 26 (suppl 3); 61- 66 : 2011
90. Spiller R, Garsed K : Postinfectious irritable bowel syndrome. Gastroenterology 136; 1979-1988 : 2009
91. Thabane M, Kottachchi DT, Marshall JK : Systematic review and meta-analysis : The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 26; 535-544 : 2007
92. Grossberg AJ, Zhu X, Leinninger GM, et al : Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci 31; 11376-11386 : 2011